A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS

Clinical trial NCT05053035 · TERMINATED

Trial details

NCT number: NCT05053035
Sponsor: Alector Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-09-02
Primary completion: 2022-10-28
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.